5,7-dihydroxytryptamine has been researched along with Encephalopathy, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, JD; Irvine, KA; Liang, DY; Sahbaie, P; Shi, X | 1 |
| Clark, JD; Ferguson, AR; Irvine, KA; Sahbaie, P | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Mild Traumatic Brain Injury Causes Nociceptive Sensitization through Spinal Chemokine Upregulation.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzamides; Brain Injuries, Traumatic; Chemokine CXCL1; Chemokine CXCL2; Cyclobutanes; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fenclonine; Immunohistochemistry; Male; Mice; Ondansetron; Real-Time Polymerase Chain Reaction; Receptors, Interleukin-8B; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3 | 2019 |
Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Uptake Inhibitors; Animals; Brain Injuries, Traumatic; Capsaicin; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neural Pathways; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2020 |